{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-065057","form_type":"8-K","ticker":"HURA","cik":"0001498382","company_name":"TuHURA Biosciences, Inc./NV","filed_at":"2025-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.485824+00:00","generated_at":"2026-05-22T07:43:22.530993+00:00","sec_items":["1.01","5.02","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"TuHURA amends Kineta merger; revises consideration, extends end date to June 30, 2025","bullets":["First Amendment revises merger consideration: Initial Stock Consideration based on $16.5M less adjustments at $5.7528/share.","Delayed Stock Consideration set at $6.5M less liabilities and working capital deficits, divided by share value and fully diluted shares.","Cash Consideration base $12M, with credits for $5M exclusivity, $300K extension, $695K advances, loaned amount, and working capital adjustment.","End Date extended to June 30, 2025; closing condition requires TuHURA to receive at least $20M from concurrent investment.","CSO Dennis Yamashita terminated Dec 16, 2024; severance $145,833 over 5 months, COBRA 6 months, options vest on 65,597 shares."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-065057","json":"https://secwatch.observer/filing/0000950170-25-065057.json","markdown":"https://secwatch.observer/filing/0000950170-25-065057.md","text":"https://secwatch.observer/filing/0000950170-25-065057.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1498382/000095017025065057/0000950170-25-065057-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1498382/000095017025065057/hura-20250505.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T07:43:22.530993+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7bce9a16e6","claim":"Dennis Yamashita was terminated as Chief Scientific Officer at TuHURA Biosciences, Inc./NV.","evidence_excerpt":"the Separation Agreement confirms that Mr. Yamashita’s employment with TuHURA terminated effective December 16, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1498382/000095017025065057/0000950170-25-065057-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Chief Scientific Officer"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}